121 related articles for article (PubMed ID: 9628549)
1. The selective estrogen receptor modulator, raloxifene: reproductive assessments following preimplantation exposure in mated female rats.
Clarke DO; Griffey KI; Buelke-Sam J; Francis PC
Reprod Toxicol; 1998; 12(3):247-59. PubMed ID: 9628549
[TBL] [Abstract][Full Text] [Related]
2. The selective estrogen receptor modulator, raloxifene: a segment II/III delivery study in rats.
Buelke-Sam J; Cohen IR; Wierda D; Griffey KI; Fisher LF; Francis PC
Reprod Toxicol; 1998; 12(3):271-88. PubMed ID: 9628551
[TBL] [Abstract][Full Text] [Related]
3. The selective estrogen receptor modulator, raloxifene: reproductive assessments following premating exposure in female rats.
Hoyt JA; Fisher LF; Buelke-Sam JL; Francis PC
Reprod Toxicol; 1998; 12(3):233-45. PubMed ID: 9628548
[TBL] [Abstract][Full Text] [Related]
4. The selective estrogen receptor modulator, raloxifene: segment II studies in rats and rabbits.
Byrd RA; Francis PC
Reprod Toxicol; 1998; 12(3):261-70. PubMed ID: 9628550
[TBL] [Abstract][Full Text] [Related]
5. The selective estrogen receptor modulator, raloxifene: an overview of nonclinical pharmacology and reproductive and developmental testing.
Buelke-Sam J; Bryant HU; Francis PC
Reprod Toxicol; 1998; 12(3):217-21. PubMed ID: 9628546
[TBL] [Abstract][Full Text] [Related]
6. The selective estrogen receptor modulator, raloxifene: reproductive assessments in adult male rats.
Hoyt JA; Fisher LF; Swisher DK; Byrd RA; Francis PC
Reprod Toxicol; 1998; 12(3):223-32. PubMed ID: 9628547
[TBL] [Abstract][Full Text] [Related]
7. Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats.
Weisenburger WP; Hagler AR; Tassinari MS
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):171-84. PubMed ID: 15282738
[TBL] [Abstract][Full Text] [Related]
8. Reproductive toxicity of exemestane, an antitumoral aromatase inactivator, in rats and rabbits.
Beltrame D; di Salle E; Giavini E; Gunnarsson K; Brughera M
Reprod Toxicol; 2001; 15(2):195-213. PubMed ID: 11297878
[TBL] [Abstract][Full Text] [Related]
9. Reproductive toxicity assessment of lasofoxifene, a selective estrogen receptor modulator (SERM), in female rats.
Terry KK; Cappon GD; Hurtt ME; Tassinari MS; Gupta U
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):150-60. PubMed ID: 15282736
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
11. Embryo/fetal toxicity assessment of lasofoxifene, a selective estrogen receptor modulator (SERM), in rats and rabbits.
Ozolins TR; Gupta U
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):161-70. PubMed ID: 15282737
[TBL] [Abstract][Full Text] [Related]
12. Fertility and developmental toxicity assessment in rats and rabbits with LY500307, a selective estrogen receptor beta (ERĪ²) agonist.
Hilbish KG; Breslin WJ; Johnson JT; Sloter ED
Birth Defects Res B Dev Reprod Toxicol; 2013 Oct; 98(5):400-15. PubMed ID: 24323950
[TBL] [Abstract][Full Text] [Related]
13. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
[TBL] [Abstract][Full Text] [Related]
14. Reproductive and developmental toxicity of inhaled 2,3-dichloro-1,3-butadiene in rats.
Mylchreest E; Malley LA; O'Neill AJ; Kegelman TA; Sykes GP; Valentine R
Reprod Toxicol; 2006 Nov; 22(4):613-22. PubMed ID: 16716565
[TBL] [Abstract][Full Text] [Related]
15. Gestational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) severely alters reproductive function of female hamster offspring.
Wolf CJ; Ostby JS; Gray LE
Toxicol Sci; 1999 Oct; 51(2):259-64. PubMed ID: 10543027
[TBL] [Abstract][Full Text] [Related]
16. Clinical effects of raloxifene hydrochloride in women.
Khovidhunkit W; Shoback DM
Ann Intern Med; 1999 Mar; 130(5):431-9. PubMed ID: 10068418
[TBL] [Abstract][Full Text] [Related]
17. Tavaborole, a Novel Boron-Containing Small Molecule Pharmaceutical Agent for Topical Treatment of Onychomycosis: II. Prenatal and Postnatal Developmental Toxicity and Maternal Function Study.
Ciaravino V; Coronado D; Lanphear C; Hoberman A; Chanda S
Int J Toxicol; 2016 Sep; 35(5):543-57. PubMed ID: 27138050
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
Grese TA; Cho S; Finley DR; Godfrey AG; Jones CD; Lugar CW; Martin MJ; Matsumoto K; Pennington LD; Winter MA; Adrian MD; Cole HW; Magee DE; Phillips DL; Rowley ER; Short LL; Glasebrook AL; Bryant HU
J Med Chem; 1997 Jan; 40(2):146-67. PubMed ID: 9003514
[TBL] [Abstract][Full Text] [Related]
19. Raloxifene: a selective estrogen receptor modulator.
Scott JA; Da Camara CC; Early JE
Am Fam Physician; 1999 Sep; 60(4):1131-9. PubMed ID: 10507743
[TBL] [Abstract][Full Text] [Related]
20. Hypocholesterolemic activity of raloxifene (LY139481): pharmacological characterization as a selective estrogen receptor modulator.
Kauffman RF; Bensch WR; Roudebush RE; Cole HW; Bean JS; Phillips DL; Monroe A; Cullinan GJ; Glasebrook AL; Bryant HU
J Pharmacol Exp Ther; 1997 Jan; 280(1):146-53. PubMed ID: 8996192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
